Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs) - PubMed (original) (raw)
doi: 10.1016/j.biomaterials.2020.120633. Epub 2020 Dec 28.
Davide Ceresa 2, Raphaelle Lesage 3, Federico Villa 2, Daniele Reverberi 4, Carolina Balbi 5, Sara Santamaria 6, Katia Cortese 6, Paolo Malatesta 1, Liesbet Geris 7, Rodolfo Quarto 1, Roberta Tasso 8
Affiliations
- PMID: 33453634
- DOI: 10.1016/j.biomaterials.2020.120633
Free article
Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs)
Cansu Gorgun et al. Biomaterials. 2021 Feb.
Free article
Abstract
Mesenchymal stromal cells (MSCs) are characterized by a regulatory phenotype and respond promptly to the environmental signals modulating their secretory activity. An appropriate preconditioning may induce MSCs to release secretomes with an enhanced regenerative potential. However, it fails to take into account that secretomes are composed by both soluble factors and extracellular vesicles (EVs), whose functions could be altered differently by the preconditioning approach. Here we demonstrate that the MSC secretome is strongly modulated by the simultaneous stimulation with hypoxia and pro-inflammatory cytokines, used to mimic the harsh environment present at the site of injury. We observed that the environmental variations strongly influenced the angiogenic potential of the different secretome fractions. Upon inflammation, the pro-angiogenic capacity of the soluble component of the MSC secretome was strongly inhibited, regardless of the oxygen level, while the EV-encapsulated component was not significantly affected by the inflammatory stimuli. These effects were accompanied by the modulation of the secreted proteins. On one hand, inflammation-activated MSCs release proteins mainly involved in the interaction with innate immune cells and in tissue remodeling/repair; on the other hand, when MSCs are not exposed to an inflamed environment, they respond to the different oxygen levels modulating the expression of proteins involved in the angiogenic process. The cargo content (in terms of miRNAs) of the corresponding EV fractions was less sensitive to the influence of the external stimuli. Our findings suggest that the therapeutic efficacy of MSC-based therapies could be enhanced by selecting the appropriate preconditioning approach and carefully discriminating its effects on the different secretome components.
Keywords: Angiogenesis; Extracellular vesicles; Mesenchymal stromal cells; Proteomics; RNASeq; Regenerative medicine.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
- Effects of preconditioning with TNFα and IFNγ in angiogenic potential of mesenchymal stromal cell-derived extracellular vesicles.
Cavallero S, Dekali S, Guitard N, Théry H, Hélissey C, François S. Cavallero S, et al. Front Cell Dev Biol. 2023 Dec 21;11:1291016. doi: 10.3389/fcell.2023.1291016. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38178868 Free PMC article. - Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease.
Ragni E, Perucca Orfei C, De Luca P, Mondadori C, Viganò M, Colombini A, de Girolamo L. Ragni E, et al. Stem Cell Res Ther. 2020 Apr 28;11(1):165. doi: 10.1186/s13287-020-01677-9. Stem Cell Res Ther. 2020. PMID: 32345351 Free PMC article. - Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo.
Cheng A, Choi D, Lora M, Shum-Tim D, Rak J, Colmegna I. Cheng A, et al. Stem Cell Res Ther. 2020 Dec 14;11(1):539. doi: 10.1186/s13287-020-02050-6. Stem Cell Res Ther. 2020. PMID: 33317598 Free PMC article. - Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content.
Mardpour S, Hamidieh AA, Taleahmad S, Sharifzad F, Taghikhani A, Baharvand H. Mardpour S, et al. J Cell Physiol. 2019 Jun;234(6):8249-8258. doi: 10.1002/jcp.27669. Epub 2018 Oct 30. J Cell Physiol. 2019. PMID: 30378105 Review. - Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives.
Guo H, Su Y, Deng F. Guo H, et al. Stem Cell Rev Rep. 2021 Apr;17(2):440-458. doi: 10.1007/s12015-020-10085-8. Epub 2020 Nov 19. Stem Cell Rev Rep. 2021. PMID: 33211245 Free PMC article. Review.
Cited by
- Hypoxic extracellular vesicles from hiPSCs protect cardiomyocytes from oxidative damage by transferring antioxidant proteins and enhancing Akt/Erk/NRF2 signaling.
Bobis-Wozowicz S, Paw M, Sarna M, Kędracka-Krok S, Nit K, Błażowska N, Dobosz A, Hammad R, Cathomen T, Zuba-Surma E, Tyszka-Czochara M, Madeja Z. Bobis-Wozowicz S, et al. Cell Commun Signal. 2024 Jul 9;22(1):356. doi: 10.1186/s12964-024-01722-7. Cell Commun Signal. 2024. PMID: 38982464 Free PMC article. - Spheroid size influences cellular senescence and angiogenic potential of mesenchymal stromal cell-derived soluble factors and extracellular vesicles.
Rovere M, Reverberi D, Arnaldi P, Palamà MEF, Gentili C. Rovere M, et al. Front Bioeng Biotechnol. 2023 Dec 12;11:1297644. doi: 10.3389/fbioe.2023.1297644. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38162179 Free PMC article. - Priming mesenchymal stem cells to develop "super stem cells".
Haider KH. Haider KH. World J Stem Cells. 2024 Jun 26;16(6):623-640. doi: 10.4252/wjsc.v16.i6.623. World J Stem Cells. 2024. PMID: 38948094 Free PMC article. - Menstrual blood-derived mesenchymal stromal cells: impact of preconditioning on the cargo of extracellular vesicles as potential therapeutics.
de Pedro MÁ, López E, González-Nuño FM, Pulido M, Álvarez V, Marchena AM, Preußer C, Szymański W, Pogge von Strandmann E, Graumann J, Sánchez-Margallo FM, Casado JG, Gómez-Serrano M. de Pedro MÁ, et al. Stem Cell Res Ther. 2023 Jul 28;14(1):187. doi: 10.1186/s13287-023-03413-5. Stem Cell Res Ther. 2023. PMID: 37507751 Free PMC article. - hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages.
Guo F, Pan Q, Chen T, Liao S, Li S, Li A, Chen S, Chen J, Xiao Z, Su H, Yang L, Yang C, Liu HF, Pan Q. Guo F, et al. Stem Cell Res Ther. 2023 Aug 21;14(1):211. doi: 10.1186/s13287-023-03432-2. Stem Cell Res Ther. 2023. PMID: 37605271 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases